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                                        INTRODUCTION
Thyroid dysfunction is a common cause of AUB and accounts for 25-
35%  of  cases  (Koutras  DA,  1997).  Thyroid  disorders  are  10  times  more 
common in women than men (Sisan et  al,  1987).  Approximately 1% of the 
female  population  will  develop  overt  hypothyroidism  (Turnbridge  WMG, 
1977,) 
    Abnormal  menstrual  cycles  are  occasionally  the  first  sign  of 
hypothyroidism and  hyperthyroidism. (Wilansky DL, Griesman B, 1992)  
The clinical  objective is  to detect  and treat  thyroid disease  before the 
symptoms  and  signs  are  significant  and  intense.  Therefore  the  key  to  early 
diagnosis is to maintain a high index of suspicion and to readily screen for the 
presence  of  abnormal  thyroid  function.  Moreover,  thyroid  dysfunction  is  an 
easily  correctable  cause  of  AUB.  Appropriate  treatment  is  rewarded  by  the 
prompt return of normal menstrual cycles.
                                 AIM OF THE STUDY
The  study  is  aimed  at  a  cross-  section  of  population  presenting  to  the 
department of Obstetrics and Gynecology at the Government RSRM Lying- in 
Hospital,  Stanley  Medical  College  with  complaints  of  abnormal  uterine 
bleeding. The study aims to ascertain the following. 
1) The  association  between  thyroid  dysfunction  and  AUB  in  the 
reproductive age group (18-45 years).
2)    To study the thyroid abnormalities in different types of AUB in the 
reproductive age group. 
3) To establish if screening for thyroid abnormalities is justified using T3  , 
T4 and TSH.
REVIEW OF LITERATURE
1. Gardner  and  Hill  in  1927  showed  an  association  between 
hypothyroidism and menorrhagia
2. Goldsmith  et  al  in  1952  found  that  8  out  of  10  patients  with 
hypothyroidism  had  anovulation  with  only  2  experiencing  normal 
ovulation and menses. 
3. Rogers et al 1958 stated that the most common abnormality observed by 
hypothyroid women is a change in the character of uterine bleeding and 
length of the cycle. 
4. Scott  in  1964  found  that  56%  of  woman  with  hypothyroidism  had 
abnormal menstrual patterns with menorrhagia being the most common. 
5. Blum  and  Blum  in  1972  have  studied  the  relationship  between 
subclinical hypothyroidism and menorrhagia.
6. Geenspan et al in 1975 advocated the empirical use of the thyroxine. But 
in 1999, prentice et al have stated that the empirical use of thyroxine is 
controversial. They have condemned it and advocated the use of TRH in 
women with AUB and normal T3, T4, and TSH. 
7. Akande  in  1975  stated  that  changes  in  FSH/LH  ratios  caused 
anovulatory cycles in hypothyroidism. 
8. Andrew  weeks  in  1987  in  his  study  of  650  women  with  menstrual 
disturbances at the Jessop hospital has stated that hypothyroidism is a 
greatly under diagnosed causes of menorrhagia. 
9. Keye WR, Yuen B Knopff in 1976 have stated that hyperprolactinemia 
causing  luteal  phase  defect  is  associated  with  less  severe  forms  of 
hypothyroidism  
10. Robuschi et al in 1987 have stated that hypothyroidism increases with 
age and is more common in older women. Upto 45% of thyroid  glands 
from women over  60 show evidence  of  thyroiditis.  The incidence of 
anti-thyroglobulin  antibodies  is  7.4%  in  women  over  age  75  while 
16.9%  of  woman  aged  60  and  17.4%  of  woman  over  age  75  have 
elevated TSH levels. In women admitted to geriatric wards, 2-4% have 
clinically apparent hypothyroidism  
11.  Klee et al in 1987 have shown the significance and positive predictive 
value of TSH assay in thyroid functions tests. They are of opinion that 
TSH based  testing  strategies  minimize  the  problems  of  abnormal  T4 
study  and  significantly  reduce  the  number  of  TRH  stimulation  tests 
performed. 
12. Smith et al in 1987 showed an association between hypothyroidism and 
menorrhagia  with  development   of  an  advanced  form  of  von 
willebrand’s  disease  in  untreated  hypothyroidism  .  The  hemostatic 
defects returned to normal with thyroxine supplementation. 
13. Bleney et al in 1990 confirmed the findings of Smith et al. Hingham in 
1992 reported a case of hypothyroidism in which menstrual  loss was 
measured. An initial loss of 480 ml decreased to 58 ml following a 3 
months treatment with thyroxine. 
14. wilansky et al in 1992 performed thyrotropin releasing hormone (TRH) 
test in 67 women who complained of excessive menstrual loss. All had 
normal  levels  of  thyroxine  and  thyroid  stimulating  hormone  (TSH). 
They found that 22% had abnormal TRH tests and they treated these 
women with thyroxine. At follow up between 12 and 36 months later, all 
considered their  menstrual  loss  to  be  normal.  In  the 16 women with 
normal TRH tests, 56% still complained of menorrhagia. 
15.  Blum  and  Blum  in  1992  studied  the  possible  relationship  between 
menorrhagia and occult hypothyroidism   in IUD- wearing women. They 
studied  40  women  with  menorrhagia  secondary  to  an  intrauterine 
contraceptive  device.  They  all  had  normal  free  thyroxine  and  TSH 
levels. The 10 patients who had the highest TSH levels were given a 
TRH  test  and  all  proved  to  have  early  hypothyroidism.  All  patients 
reported a significant improvement with thyroxine treatment. This recent 
development deserves further study. 
16.  Danese MD et al in 1996 have stated that hypothyroidism is frequent 
enough  to  warrant  consideration  in  most  older   women.  They 
recommend screening with highly sensitive TSH assay every 5 years 
beginning at age 35 and then  every two years beginning at age 60 or 
with the appearance of any symptom suggesting hypothyroidism  
17. Chameron and Fraser in 1998 in their study on the clinical disorders of 
the  endometrium  and  the  menstrual  cycle  have  stated  that  thyroid 
disorders are the most common endocrine abnormality associated with 
menstrual  disturbances.  Hypothyroidism  is  a  potent  cause  of 
menorrhagia which is amenable to treatment. 
18. Shaw RW in 1999 conducted a large comparative analysis to study the 
effect of thyroxine replacement on menstrual blood loss in hypothyroid 
patients. There was a relative improvement in hemoglobin concentration 
and general condition of the patients. 
19.   Prentice et al  – Medical  Management of Menorrhagia – 1999 have 
stated that all women with unexplained menorrhagia should be tested for 
thyroid dysfunction. 
 The review of literature suggests that there is a strong correlation between 
AUB and thyroid dysfunction.  It  stands as an easily correctable cause of 
AUB.
PHYSIOLOGY OF MENSTRUATION
Menstruation is a very recent phenomenon in the evolutionary time line. It 
occurs in very few species even among viviparous animals.The diagnosis and 
management  of  abnormal  menstrual  function  must  be  based  on  an 
understanding of the physiologic mechanisms involved in the regulation of the 
normal cycles. Although the activity of the endometrium is directly controlled 
by the ovarian function and by the two hormones secreted by the ovary, the 
ovary itself is activated by the pituitary gland, the secretion of which is under 
the nervous control of the hypothalamus. 
The  normal  human  menstrual  cycle  can  be  divided  into  two  segments:  the 
ovarian cycle and the uterine cycles based on the organ under examination. The 
ovarian cycle may be further divided into follicular and luteal phases, whereas 
the uterine cycle is divided into the corresponding proliferative and secretory 
phases. 
(1) At  the beginning of  each monthly  menstrual  cycle,  levels  of  gonadal 
steroids are low and have been decreasing since the end of the luteal 
phase of the previous cycle. 
(2) With the demise of the corpus luteum, FSH levels begin to rise and a 
cohort  of  growing  follicles  is  recruited.  These  follicles  each  secrete 
increasing levels of oestrogen as they grow in the follicular phase. This 
in turn, is the stimulus for uterine endometrial proliferation. 
(3) Rising oestrogen levels provide a negative feed back on pituitary FSH 
secretion which begins to wane by the midpoint of the follicular phase. 
Conversely, LH initially decreases in response to rising estradiol levels 
but  late in the follicular  phase the LH level  is  increased dramatically 
(biphasic response).
(4) At the end of the follicular phase (just prior to ovulation), FSH induced 
LH receptors are present on granulosa cells and with LH stimulation, 
modulate the release of Progesterone. 
(5) After  a  sufficient  degree  of  oestrogenic  stimulation,  the  pituitary  LH 
surge  is  triggered,  which  is  the  proximate  cause  of  ovulation  which 
occurs  24-36  hours  latter.  Ovulation  heralds  the  transition  to  luteal 
secretory phase. 
(6) The oestrogen level decreases through the early luteal phase from just 
before ovulation until the midluteal phase when it begins to rise again as 
a result of corpus luteum secretion. 
(7) Progesterone levels rise precipitously after ovulation and can be used as 
a presumptive sign that ovulation has occurred.  
(8) Both oestrogen and progesterone levels remain elevated throughout the 
life of the corpus luteum and then wane with its demise, thereby setting 
the stage for the next cycle. 
(9) In  the  absence  of  implantation,  glandular  secretion  ceases  and  an 
irregular breakdown of the decidua functionalis occurs. The result is a 
shedding of this layer of the endometrium , a process termed menses. 
THE NORMAL MENSTRUAL CYCLE
A normal menstrual cycle lasts from 21 to 35 days with 2 to 6 days of flow and 
an average blood loss of 20-60ml. (Vollman RF, 1977 and Treloar AE, 1967). 
However studies of large numbers of women with normal menstrual cycles have 
shown that only approximately two- thirds of adult women have cycles lasting 
21-35  days  (Friedman  E,  1977).  The  extremes  of  reproductive  life  are 
characterized by a higher percentage of anovulatory or irregularly timed cycles 
(Collett ME et al, 1954).
DEFINITION OF MENSTRUAL CYCLE IRREGULARITIES
(1) oligomenorrhea : Infrequent, irregularly timed episodes 
Of bleeding usually occurring at 
interval of more than  35 days 
(2) Polymenorrhea : Frequent but regularly timed episodes 
of bleeding usually occurring at 
interval of 21 days or less. 
(3) Menorrhagia : Regularly timed episodes of bleeding 
That are excessive in amount (>80 ml) 
         or duration of flow (>5days).
(4) Metrorrhagia : Inter menstrual bleeding
(5) Menometrorrhagia : Excessive, prolonged bleeding that 
Occurs at irregularly timed, frequent 
Intervals 
(6) Hypomenorrhea : Regularly timed bleeding that is 
decreased in amount. 
 (7) Amenorrhea : Absence of menstruation for three 
Normal cycles or six moths. 
THE THYROID GLAND
Thomas Wharton in 1656,  gave the thyroid gland its modern name. For 
unknown reasons,  thyroid  disease  is  more  common  in  women  than  in  men 
(Medvei VC, 1993)
Normal thyroid Physiology
Thyroid hormone synthesis depends on an adequate supply of iodine in the diet. 
It  is  absorbed as iodide and enters  the thyroid under  the influence  of  TSH. 
Within the gland iodide is oxidized to elemental iodine which is then bound to 
tyrosine.  Mono  and  di-iodotyrosines  combine  to  form  thyroxine  (T4)  and 
triiodothyronine(T3)  (Norman AW, Litwack G, 1987).  These  compounds are 
part  of  the  thyroglobulin  molecule  which  serves  as  a  storage  depot  for  the 
thyroid hormone. TSH induces a proteolytic enzyme that result in the release of 
iodothyronines into the bloodstream as thyroid hormone. Removal of one iodine 
from the phenolic ring of T4 yields  T3
One –  third  of  T4 Secreted  each  day  is  converted  in  the  peripheral  tissues, 
largely in the liver and kidney to T3   and about 40% is converted into inactive 
Reverse T3. Although T4 in secreted at 20 times the rate of T3 ,T3 is responsible 
for most of the thyroid action in the body (Czarnocka B et al, 1985).
Mechanism of Thyroid  Hormone  Action 
Thyroid hormone acts  by binding to  a  specific  nuclear  DNA bound thyroid 
hormone receptor (TR) usually as a hetero dimer with the retinoid X receptor 
(RXR) at specific sequences dictated by the DNA binding site preferences of 
the RXR-TR complex. T3 has a 15 fold higher   binding affinity for TR than 
does T4 which explains its function as the active thyroid hormone (Brent GA, 
1994)
Bound and free fractions of Thyroid Hormones 
Thyroid  hormones  present  in  circulation  are  mainly  bound  to  proteins. 
Approximately  70%  of  thyroid  hormones  are  bound  to  thyroxine  binding 
globulin (TBG).The remaining 30% is bound to thyroxin binding prealbumin 
and albumin. The binding proteins have greater affinity for T4 and thus allow T3 
to have a greater entry into the cells. TBG is synthesized in the liver and the 
synthesized in the liver and the synthesis is increased by oestrogens. 
Regulation of thyroid hormone secretion – Role of estrogens 
Thyroid hormones regulate TSH secretion by suppressing TRH secretion, but 
primarily  affect  the pituitary sensitivity  to  TRH,  by reducing the number  of 
TRH receptors. Pituitary secretion of TSH is very sensitive to changes in the 
circulating level of thyroid hormone. A slight change in the circulating level of 
T4 will produce a many fold greater response in TSH. TSH  secreting cells are 
regulated by T4  but only after the T4 is converted to T3 in the pituitary cells. 
Although some tissues depend mainly on the blood T3 for their intracellular T3, 
the brain and pituitary depend on their own intracellular conversion of T4
The  measurement  of  T3,T4  and  TSH  therefore  provides  the  most  accurate 
assessment of thyroid function. 
The  TSH  response  to  TRH  is  influenced  mainly  by  the  thyroid  hormone 
concentration in the circulation. Estrogen increases the TRH receptor content in 
the pituitary. Hence the TSH response to TRH is greater in women than in men 
and greater in women taking oral contraceptives. 
The smallest doses of the TRH that  are capable of producing an increase in 
TSH also increase the prolactin levels indicating a physiologic role for TRH in 
the control of prolactin secretion. 
Thyroid Function Tests 
Serum thyroid hormones are measured by radio- immunoassay. Conditions that 
elevate the TBG (pregnancy, oestrogen replacement, use of oral contraceptive 
pills, hepatitis) necessitate measurement of T3 resin uptake for clarification   
(1) Free  Thyroxine  (FT4):  Assays  that  measure  free  T4 are  usually 
displacement  assays  using  an  autoantibody  to  T4.  The  result  is  not 
affected by changes in TBG and binding. 
(2) Total thyroxine (T T4): The total thyroxine, both the portion bound to 
TBG and the free unbound portion is measured by displacement assays 
and in the absence of hormone therapy and other illnesses estimates the 
thyroxine concentration in the blood. 
(3) TSH:  TSH  is  measured  by  highly  sensitive  assays  that  can  detect 
concentrations as low as 0.01μu/L. This is a very sensitive indicator of 
thyroid hormone action at tissue level because it is dependent on the 
pituitary exposure to T4  .  In the absence of hypothalamic or pituitary 
disease,  the sensitive  TSH assays will  provide the best  indication of 
excess or deficient  thyroxine, slight  changes in T4   are reflected in a 
many fold greater response in TSH. Transient changes in TSH are seen 
in  severe  systemic  illness,  psychiatric  illness,  adrenal  insufficiency, 
corticosteroid  therapy,  elevated  HCG  (Since  HCG  can  stimulate  the 
TSH receptor) and in any acute illness. 
(4) Total  T3 and  Reverse  T3:  These  are  rarely  required  for  the  accurate 
evaluation of  a patient  with an abnormal  TSH level  and are of  little 
value in clinical circumstances. Serum T3 is almost always an indirect 
reflection of the serum T4 supply (Berghout A, 1994)
Other tests include the free thyroxine index and radioactive iodine uptake. 
THE LABORATORY EVALUATION 
For screening purposes or when there is a relatively low clinical suspicion of 
thyroid disease, the initial step is to measure the TSH by a sensitive assay. A 
normal TSH essential excludes hypo/ Hyperthyroidism. A high TSH requires 
the measurement of free T4   to confirm the diagnosis of hypothyroidism. If 
the initial TSH is low, especially less than 0.08 μu/ml, then measurement of 
high T4 will confirm the diagnosis of hyperthyroidism. If T4 is normal, the 
T3  level  is  measured  since  some  patients  will  have  predominately  T3 
toxicosis, 
If T3  is normal it implies that thyroxine secretion is autonomous from TSH 
and this is called subclinical hyperthyroidism. Some of these patients will 
eventually have increased T4 or T3 levels with true hyperthyroidism. 
The algorithm represents a cost-effective and accurate clinical strategy.
                                                        
 
                 
(Surks  MI,  chopra  H,  Mariesh  CN,  Nicoloff  JT,  solomon,  TH  American 
Thyroid Association guidelines for use of laboratory tests in thyroid disorders, 
JAMA 263:1529, 1990)
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Role of Thyroid in Reproductive physiology/ Pathology 
The  following  facts  emphasis  the  role  of  thyroid  hormone  in  the  female 
reproductive  physiology. 
(1) TSH receptors have been found on granulosa cells. 
(2) T3 and T4 have been found in follicular fluids. 
(3) T4  has  been  found  to  enhance  the  action  of  gonadotrophins  in 
luteinisation and progesterone secretion 
The female hormonal milieu and its potential effects on immune surveillance 
undoubtedly play a role in the increased  risk (10 fold) of women to develop 
autoimmune thyroid disease  (Gaitan E et  al,  1985 and Wenzel  BE et  al, 
1987).  The immunoglobulins  produced against  the thyroid are  polyclonal 
and  the  multiple  combinations  of  various  antibodies  present  combine  to 
create  the  clinical  spectrum  of  autoimmune  thyroid  diseases  that  affect 
successful reproductive function. 
Foetal and neonatal period. 
Very  few  data  exist  regarding  the  role  of  the  thyroid  hormones  in  the 
reproductive system of the foetus. No effective human studies are available. 
Thyroid  excess  in  mice  is  shown  to  cause  early  maturation  of  the 
reproductive tract and early opening of the vagina. Hypothyroidism in mice 
causes small ovaries deficient in cholesterol. No change has been observed 
in human fetuses. 
Hypothyroidism 
(i) Prepubertal /Pubertal 
 In  both  sexes,  thyroid  hormones  influence  sexual  development  and 
reproductive function. 
Infantile hypothyroidism, if untreated, leads to sexual immaturity. Juvenile 
hypothyroidism  causes  a  delay  in  the  onset  of  puberty  followed  by 
anovulatory cycles. 
Paradoxically,  primary  hypothyroidism may also  cause  precocious  sexual 
development and galactorrhea. (Kleinberg DL, New England J.Med. 1977). 
The  McCune  Albright  syndrome  is  characterized  by  hyperfunctioning 
endocrinopathies including hyper/hypothyroidism and sexual precocity, but 
the  association  may  be  coincidental  (Albright  F,  Maine  MJ,  1938). 
Precocious puberty with delayed bone age suggests primary hypothyroidism. 
Serum TSH is increased, T4 is low and galactorrhea may be  present with 
increased  serum  prolactin  (Honbo  KS  et  al,  1978).  (Kindle  et  al)  have 
described  a  syndrome  of  precocious  menstruation,  galactorrhea  and  sella 
enlargement in girls with juvenile hypothyroidism. 
2. In adult women 
Severe hypothyroidism is associated with  diminished libido, amenorrhea or 
anovualtion  (Grodstein  F  et  al,  1993).  Secretion  of  progesterone  is 
inadequate and endometrial proliferation persists resulting in excessive and 
irregular  breakthrough menstrual  bleeding.  These  changes may be due to 
deficient  secretion  of  luteinizing  hormone.  Rarely  in  primary 
hypothyroidism,  secondary  depression  of  pituitary  function  may  lead  to 
ovarian atrophy and amenorrhea. Hypothyroidism appears to be associated 
with  decreased  fertility  resulting  form  ovulatory  difficulties,  and 
spontaneous  abortions  may  result,   although  many  pregnancies  are 
successful. (Lao TTH et al, 1988 and Morimotoc et al, 1990)
The values for plasma gonadotrophins are usually in the normal range in 
primary hypothyroidism. In postmenopausal women, levels are usually lower 
than  euthyroid  women  of  the  same  age  but  are  nevertheless  within  the 
menopausal range. This provides a valuable means of differentiating primary 
from secondary hypothyroidism.(Melmed S,Hershman J,1982)
Myxedematous  infiltration can produce enlarged ,  cystic  ovaries  (Kansen 
KA et al, 1997) 
There  may  be  a  high  incidence  of  early  or  potential  hypothyroidism  in 
women  presenting  with  menorrhagia.  Hypothyroidism  can  cause 
menorrhagia/ polymenoorrhea.-these symptoms being present in 30-40% of 
the cases. (Koutras DA, 1997)
Metabolism of oestrogens in hypothyroidism
The metabolism of oestrogens is also  altered. With respect to oestradiol and 
oestrone, hypothyroidism favours the metabolism of these steroids via 16 α –
hydroxylation over that via 2 –oxygenation with the result that the formation 
of oestriol is increased and that of 2-hydroxyoestrone and its derivative 2-
methoxyoestrone is decreased. The sex hormone binding globulin (SHBG) 
concentrations  in  plasma  is  decreased  with  the  result  that  the  plasma 
concentrations  of  both  testosterone  and  oestradiol  are  decreased,  but  the 
unbound fractions are increased. The alterations in steroid metabolism are 
corrected by restoration of the euthyroid state (Brenta GA,et al, variation of 
SHBG in thyroid dysfunction, 1999).
Effects of hypothyroidsm on the GnRH  pulsatality. 
TSH is secreted by the pituitary and its excess production causes menstrual 
abnormality due to its adverse effects on the GnRH pulse generator and not 
by directly affecting the ovary. When there is decrease in GnRH  pulsatality, 
anovulation can occur. Even slight changes in pulsatality may result in luteal 
phase defect (Del pozo, 1979 and warfel W, 1992).
Primary hypothyrodism and hyperprolactinemia   
Hyperprolactinemia  and  anovulation  may  be  associated  with  primary 
hypothyroidism Remarkable  enlargement  of  the  pituitary  with  thyrotroph 
hyperplasia  and  hyperprolactinemia  is  frequently  seen  in  long  standing 
primary hypothyroidism (Franks et al, 1975)
A number of mechanisms may be involved. 
1) The clearance of prolactin tends to be decreased in hypothyroidism 
(Warfel W, 1992)
2) Patients with severe hypothyroidism may have elevated total and free 
estradiol  levels  giving  rise  to  increased  prolactin  production 
stimulated by excess free oestrogen (Tolis G et al, 1979).
3) The third and the most significant mechanism involves the inhibitory 
effects of T3 on TRH production and  on TRH receptor expression. A 
decrease  in  the  T3  feedback  in  hypothyroidism  may  induce  and 
increase in the hypothalamic TRH production and in the number of 
TRH  receptor  in  the  lactotroph.  Increased  TRH    action  on  the 
lactotroph in turn may stimulate prolactin secretion (Collu R, 1986.)
The  duration  of  hypothyroidism  in  important  with  regard  to  the 
mechanism  of  amenorrhea-  the  longer  the  duration,  the  higher  the 
incidence of  amenorrhea  and higher the prolactin levels.  This  may be 
associated  with  decreasing  hypothalamic  content  of  dopamine  with 
ongoing  hypothyroidism.  This  would  lead  to  an  unopposed  TRH 
stimulatory effect  on the pituitary cells that secrete prolactin. Constant 
stimulation  by  the  hypothalamic  releasing  hormones  can  result  in 
hypertrophy or hyperplasia of the pituitary (Keye  WR, 1976).
Subclinical Hypothyroidism 
This term designates a situation in which an asymptomatic patient has a 
low normal  FT4I  (Free thyroxine index)  but  a  slightly  elevated serum 
TSH level.  The TSH elevation in these patients is  modest  with values 
typically between 5 and 15mu/L. It occurs in 5-10% of women. 
Effects of Hyperthyroidism on Reproductive Function 
The two primary causes of hyperthyroidism are Grave’s disease (toxic 
diffuse goiter) and plummer’s disease (toxic nodular goiter) (Lazarus JH 
in  Lancet  349,1997).  Thyrotoxicosis  in  early  life  may  cause  delayed 
sexual maturation although physical development is normal and skeletal 
growth  maybe  accelerated  .Menstrual  changes  associated  with 
hyperthyroidism  are  unpredictable,  ranging   from  amenorrhea  to 
oligomenorrhea and normal cycles. The intermenstrual interval may be 
prolonged  or  shortened,  menstrual  flow  is  initially  diminished  and 
ultimately ceases (McKenzie JM, 1979). Fertility  maybe reduced and 
the risk of miscarriage is increased.  In some patients menstrual  cycles 
are  predominantly  anovulatory  with  oligomenorrhea.  In  most  patients, 
however, ovulation occurs as is indicated by the secretory endometrium 
(Reid  Rl,  1987).  Hyperthyroidism  seldom  causes  amenorrhea  unless 
exophthalmos is present.
The mechanisms involved may be the following:
(i) Increased SHBG levels decrease the clearance of testosterone and 
estradiol.  Increased  peripheral  aromatisation  of  androgens  gives 
rise   to  oestrogens due to the increase in peripheral  blood flow 
(Thomas R, 1987)
(ii) Another more likely mechanism is the disruption in the amplitude 
and  frequency  of  LH  /FSH  pulses  due  to  thyroid  hormone 
influences on GnRH signaling (DeGroot N, 1979),
Subclincal Hyperthyroidism 
The  presence  of  a  chronically  suppressed  serum  TSH  level  with 
peripheral free thyroid hormones in the normal range is called subclinical 
hyperthyroidism.  The  incidence  is  0.9%.progression  to  overt 
hyperthyroidism is uncommon. The incidence increases in older women 
(Felicetta JU, 1987)
Screening for primary hypothyroidism 
Only  a  few  patients  with  amenorrhea/  galactorrhea  will  have 
hypothyroidism  that  is  not  clinically  apparent.  Although  it  seems 
extravagant to measure the TSH in such a large number of patients for 
such a small return, because the treatment of hypothyroidism is so simple 
and  is  rewarded  by  a  prompt  return  of  menstrual  cycles,TSH 
measurement is warranted (Caldwell G, 1985).
The high incidence of hypothyroidism in women, particularly if the 7-
10% prevalence of subclinical hypothyroidism is included raises the issue 
of whether the cost of systematic  periodic screening of an asymptomatic 
population  is  justified  (Westman  AP,  BMJ,  1997).  The  conclusions 
depend to a great extent on the assumptions regarding the effectiveness 
and  economic  value  of  therapy  in  asymptomatic   patients  with  TSH 
elevation alone. An assessment of TSH  levels at 5 years intervals in older 
women (greater than 50 years ) seems justified, but further analysis of 
more extensive screening programs are in order (P.Reid Larsen and Terry 
F. Davies, 2003).
Prediction of disease onset 
Patients  with  increased  TSH  and  normal  T4 levels  progress  to  overt 
thyroid failure at a rate of about 5% per year if thyroid auto antibody 
levels are elevated. If the serum TSH  alone is elevated without positive 
thyroid  antibody   titres,  the  annual  risk  for  hypothyroidism  drops  to 
approximately 3% per year. Most clinicians therefore treat women who 
have  elevated serum TSH concentrations and positive thyroid antibody 
tests  even in the absence of symptoms. (Vanderpump MPJ, Turnbridge 
WMG, 1996)
Thyroid  dysfunction  and  menstrual  disturbances  in  specific 
conditions 
1) Anorexia nervosa 
The various problems associated with anorexia represent a dysfunction of 
the  body  mechanisms  regulated  by  the  hypothalamus.  Anorexics  are 
usually  amenorrhic.  Many symptoms can be explained by the state  of 
relative hypothyroidism. There appears to be a compensation for the state 
of malnourishment with diversion from the formation of  active T3 to the 
inactive  metabolite  reverse  T3 -a  state  of  chemical  hypothyroidism 
(Herzog DB Copeland PM, 1985)
Exercise and stress induced amenorrhea. 
2) In patients with exercise induced amenorrhea, there is decrease in the 
frequency of GnRH pulses which is assessed by measuring a decrease 
in  the  frequency  of  LH  pulses  (Olson  BR,  1989).  Athelets  have 
relatively  low  T4 levels  but  amenorrhic  atheletes  have  an  overall 
suppression of all circulating thyroid hormones including reverse T3. 
These patients are usually hypoestrogenic, but less severe alterations 
may cause minimal menstrual dysfunction (Anovualtion /luteal phase 
defect) (Gennazani AR et al, 1991)
3) Turners syndrome 
Patients  with Turners, characterized by 45XO  karyotype have a 
short  stature,  primary  amenorrhea  and  other  abnormalities.  A  high 
prevalence  of  autoimmune  thyroid  disorders  is  noted.  Approximately 
50% of adult  patients with Turners have anti-thyroid peroxidase (anti-
TPO) and antithyroglobulin (anti TG) antibody. Approximately 30% will 
develop subclinical / clinical hypothyroidism (Barbesino G et al, 1998).
4) Postpartum thyroiditis 
 Transient thyrotoxicosis may develop within 3-6 months after delivery and is 
often followed by a period of hypothyroidism of several months duration with 
an eventual return to euthyroid state (Amino N, 1982). In some patients, only a 
hypothyroid phase is apparent. Data suggest that 8-10% of women experience 
thyroiditis in the postpartum period (Hayslip et al, 1988). Pregnancy is therefore 
an important risk factor with transient thyroiditis developing in some patients 
and  thyroid  failure  developing   permanently  or  in  the  early  years  after 
pregnancy in a significant proportion.
                                             MATERIALS AND METHODS
The  present  study  of  “thyroid  profile  in  AUB”  was  conducted  in  Govt. 
R.S.R.M. Lying in hospital, attached to Govt. Stanley medical college, Chennai. 
This is a cross-sectional study of 250 women with AUB, based on data collected 
from women with AUB attending the outpatient  department   and in-patients 
during  a  period  of  10  months  from  January  2009  to  October  2009  at  this 
hospital. The study group included women with the following complaints.
1. Oligomenorrhea           :     cycle length greater than 35 days.
2. Hypomenorrhea           :     Bleeding lasting less than 2 days.
3. Menorrhagia               :        Blood loss more than 80 ml or more.
4. Polymenorrhea              :        Cycle length less than 22 days.
5. Amenorrhea                   :       Absence of menstruation for 6 months or 3  
consecutive menstrual cycles.
Inclusion criteria
1. Women in the age group of 18-45 years.
2. Women with any of the menstrual disturbances mentioned above.
3. Women  who  do  not  have  signs  of  demonstrable  pelvic  pathology 
including PID.
4. Women with increased BMI.
5. Women who are not on any hormonal preparation.
6. Women who were not using any IUCD in the past two years.
7. Women with signs and symptoms of hypo/hyperthyroidism.
Exclusion criteria   
1. Teenage AUB
2. Age more than 45 years.
3. Presence of palpable  pelvic pathology like fibroids,  polyps or  cervical 
growths.
4. Presence of general disorders like tuberculosis.
5. Presence of diabetes, hypertension or clotting abnormalities.
6. Patients with history of bleeding diathesis.
7. Patients  on  drugs  like  aspirin,  heparin,  sulpha  drugs,  antithyroid 
medication, eltroxin, glucocorticoids, and amiodarone.
Symptoms and signs of hyperthyroidism
1. Weight loss more than 10 kg in 3 months or subjective weight loss.
2. Diarrhoea
3. Heat intolerance
4. Tremors
5. Tachycardia
6. Eye changes –exoptholmos
Symptoms and signs of hypothyroidism 
(i)     Weight gain of more than 10 kg in 3 months or subjective weight 
gain 
(ii)      Constipation 
(iii) Slow mentation/ lethargy/increased sleepiness. 
(iv) Elevated cholesterol
(v)    Coarse skin.
PROCEDURE 
Patients were selected based on the above criteria and history was taken as 
per  the  proforma  including  a  detailed  menstrual  history  and  questions 
regarding the signs and symptoms of hypothyroidism and hyperthyroidism 
were asked.The following examination was done. 
A  detailed  general   examination  focusing  specifically  on  the  presence/ 
absence  of  anemia,  thyroid  swelling  ,  cardiovascular  abnormality,  gross 
nervous  system dysfunction,  galactorrhea  and  abnormal  hair  distribution. 
The height in centimeters and weight in kilograms was measured and the 
BMI  calculated.  An  abdominal,  speculum  examination  and  pelvic 
examination were done to rule out other causes of abnormal bleeding.5 ml of 
venous  blood  was  taken  in  a  dry  plain  glass  container  without  any 
anticoagulant for TSH assay and T3,T4 estimation. Morning sample in the 
fasting state was taken. TSH assay was performed using ultrasensitives solid 
phase –two site immune radiometric assay (IRMA). IRMA- K9 kit supplied 
by Board of Radiation and isotope Technology (BRIT), Bombay was used. 
The physiological range was 0.3-6.18µIU/ml with due consideration given to 
diurnal /pulsatile variation. 
T3 and T4 was  analysed using RIA K-5/5A kit supplied by BRIT, Bombay . 
The physiological   range for  T4 was 4.8 to 11.5μg/dl.  The physiological 
range for T3 was 0.5 to 1.5 ng/ml.
                                  ANALYSIS OF THE STUDY 
After ruling out those patients with palpable organic pelvic pathology by 
gynaec examination and ultrasonogram, A total of    250 patients were included 
in the study group.
                                                      TABLE – 1
T 3 VALUES
Frequency Percentage
 < 0.5 ng/ml 34 13.6%
0.5 – 1.5 ng/ ml 206 83.6%
    >1.5 ng/ml 10 3.8%
TABLE – 2
T4 VALUES (N 4.8 – 11.5 µg/dl)
T4 (µg/dl) Number Percentage
< 4.8 34 13.6%
4.8 – 11.5 206 83.6%
      >11.5 10 3.8%
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TABLE – 3
TSH VALUES (N 0.3- 6.18 µIU/ml)
TSH (µIU/ml) Number Percentage
< 0.3 14 5.6%
0.3- 6.18 190 76%
       >6.28 46 18.4%
Among 250 patients, 190 patients had normal TSH values.  Incidence of 
Clinical hypothyroidism  was 13.6%,
         Incidence of subclinical hypothyroidism was 4.8% 
         Incidence of  clinical hyperthyroidism was 4%
         Incidence of  subclinical hyperthyroidism was 1.6%. 
TABLE -4
AGE DISTRIBUTION IN STUDY GROUP
AGE 
GROUP
Hypothyroidism Euthyroidism Hyperthyroidism
Out of 250 patients,198 patients were in the age group of 24-40 years. Among 
198 patients,42 patients were hypothyroid and 11 patients were hyperthyroid.
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
18-23 Yrs 2 6.06% 29 87.80% 2 6.06%
24-31 Yrs 26 18.05% 110 76.38% 8 5.55%
32-40 Yrs 16 29.62% 35 64.81% 3 5.55%
>40 Yrs 2 10.52% 16 84.21% 1 5.26%
TABLE 5
TYPE OF AUB IN STUDY GROUP
Type of AUB No.of patients Percentage
Oligomenorrhea 77 30.80%
Menorrhagia 109 43.60%
Amenorrhea 49 19.60%
Hypomenorrhea 7 2.80%
Polymenorrhea 8 3.20%
Majority  of  patients  in the  study group had menorrhagia(43.60%)  and 
oligomenorrhea(30.80%)
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TABLE – 6
GENERAL EXAMINATION
General Examination Number Percentage
Normal 196 78.40%
Anaemia 45 18.0%
Thyromegaly 9 3.60%
21.6% of the patients had abnormal findings on examination.  78.4% were 
normal. 
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TABLE – 7 
BODY MASS INDEX
BMI Range Hypothyroidism Euthyroidism Hyperthyroidism
Increased BMI  was found in hypothyroid patients. Decreased BMI was 
found in hyperthyroid patients. 
No.of 
pts.
Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
<18(lean) - - 2 16.66% 10 83.33%
18-24(Normal) 9 5.52% 150 92.02% 4 2.45%
25-
29(overweight)
22 40.74% 32 59.25% - -
30-34(obese
)
13 81.25% 3 18.75% - -
>35 (morbid 
obese)
2 40% 3 60% - -
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TABLE – 8
FRACTIONAL CURETTAGE
Endometrial 
curettage
Hypothyroidism Euthyroidism Hyperthyroidism
Majority of hypothyroid patients(87%) had proliferative pattern due to 
anovulation. In hyperthyroid patients both proliferative and secretory 
pattern were seen. 
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
Secretory 6 13.0% 140 73.68% 8 57.14%
Proliferative 40 87% 50 26.32% 6 42.86%
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TABLE- 9
HEMOGLOBIN ESTIMATION
Hemoglobi
n
Hypothyroidism Euthyroidism Hyperthyroidism
 Majority  of  hypothyroid  patients(65.2%)  were  anemic  due  to 
menorrhagia,whereas hemoglobin was normal in majority of hyperthyroid 
patients(71.43%)                                               
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
<7 gms% 30 65.2% 20 10.52% - -
7-9 gms% 5 10.95 30 15.795 4 28.57%
>9 gms% 11 23.9% 140 73.69% 10 71.43%
Hb <7 gms% Hb 7-9 gms% Hb >9 gms%
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                                                        TABLE 10
SIGNS AND SYMPTOMS OF HYPOTHYROIDISM
Signs/Symptoms Number of patients percentage
Constipation 10 29.4%
Cold intolerance 1 2.9%
Voice change 1 2.9%
Weight gain 20 58.8%
Lethargy 2 5.9%
Among  34  hypothyroid  patients,the  commonest  symptom  was  weight 
gain(58.8%) followed by constipation(29.4%)
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TABLE – 11
SIGNS AND SYMPTOMS OF HYPERTHYROIDISM
Signs/Symptoms Number of patients Percentage
Heat intolerance 1 10%
Anxiety 1 10%
Weight loss 1 10%
Fatigue 5 50%
Tremors 1 10%
Diarrhea 1 10%
Among 10 hyperthyroid patients,the commonest symptom was 
fatigue(50%)
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TABLE-12
AMENORRHEA-T3,T4 AND TSH VALUES
Values T3
(N=0.5-1.5 ng/ml)
T4
(N=4.8-11.5µg/dl)
TSH
N=0.3-6.18µIU/ml)
Out of 49 patients with Amenorrhea,
                               2 patients (0.8%*) had clinical hypothyroidism 
6 patients (2.4%*) had clinical hyperthyroidism
1 patient (0.4%*) had subclinical hypothyroidism
2 patients (0.8%*) had subclinical hyperthyroidism
           *→ of the total sample studied    
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
< Normal 2 4.1% 2 4.08% 8 16.32%
Normal 41 83.7% 41 83.7% 38 77.56%
>Normal 6 12.3% 6 12.3% 3 6.12%
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TABLE-13
                              MENORRHAGIA-T3,T4 AND TSH VALUES
Values T3
(N=0.5-1.5 ng/ml)
T4
(N=4.8-11.5µg/dl)
TSH
N=0.3-6.18µIU/ml)
Among 109 patients with menorrhagia,                                               
                   26 patients(10.4%*) had clinical hypothyroidism
1 patient (0.4%*) had clinical hyperthyroidism
8 patients(3.2%*) had subclinical hypothyroidism
No patient had subclinical hyperthyroidism in this 
group.
                      *→ of the total sample studied
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
< Normal 26 23.85% 26 23.85% 1 2.03%
Normal 82 75.22% 82 75.22% 74 67.89%
>Normal 1 2.03% 1 2.03% 34 31.19%
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                                                           TABLE-14
OLIGOMENORRHEA -T3,T4 AND TSH VALUES
Values T3
(N=0.5-1.5 ng/ml)
T4
(N=4.8-11.5µg/dl)
TSH
N=0.3-6.18µIU/ml)
Out of 77 Oligomenorrheic patients,
4 patients(1.6%*) had   clinical hypothyroidism
3 patients(1.2%*) had had clinical hyperthyroidism
1 patient(0.4%*) had subclinical hypothyroidism
2 patients(0.8%*) had subclinical hyperthyroidism in this 
group.
                      *→ of the total sample studied
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
< Normal 4 5.19% 4 5.19% 5 6.49%
Normal 70 90.90% 70 90.90% 67 87.01%
>Normal 3 3.90% 3 3.90% 5 6.49%
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TABLE-15
POLYMENORRHEA-T3,T4 AND TSH VALUES
Values T3
(N=0.5-1.5 ng/ml)
T4
(N=4.8-11.5µg/dl)
TSH
N=0.3-6.18µIU/ml)
Among 8 patients with polymenorrhea,
                               2patients(0.8%*) had   clinical hypothyroidism
2patients(0.8%*)  had subclinical hypothyroidism
No clinical and subclinical hyperthyroidism was noted in 
polymenorrhea patients.
No.of pts. Percentage No.of 
pts.
Percentage No.of 
pts.
Percentage
< Normal 2 25% 2 25% - -
Normal 6 75% 6 75% 4 50%
>Normal - - - - 4 50%
                      *→ of the total sample studied
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 The Findings  are summarized as follows:
TABLE-16
Incidence of Based on T3,T4 and TSH
Hypothyroidism 13.6%
Hyperthyroidism 4%
Subclinical Hypothyroidism 4.8%
Subclinical Hyperthyroidism 1.6%
In this study,Thyroid dysfunction account for 24 % in AUB patients.
The incidence of thyroid  Dysfunction in different types of AUB is as follows:
TABLE-17
AUB Hypo
thyroidism
Hyper
thyroidism
Subclinical 
hypothyroidism
Subclinical 
hyperthyroidism
Amenorrhea 0.8% 2.4% 0.4% 0.8%
Menorrhagia 10.4% 0.4% 3.2% -
Oligomenorrhea 1.6% 1.2% 0.4% 0.8%
Polymenorrhea 0.8% - 0.8% -
DISCUSSION
               AUB is a benign yet debilitating disease with a strong association with  
thyroid  disorders.  Our  study  highlights  the  association  between  AUB  and 
thyroid  dysfunction  by  measurement  of  T4 and  TSH in  the  fasting  state  in 
women with AUB.
Hypothyroidism is observed in 10.4% of women with menorrhagia, and 
0.8% of women with amenorrhea. Hyperthyroidism is seen in 1.2% of women 
with oligomenorrhea. The overall incidence of thyroid dysfunction is 24%. This 
correlates with the study by Wilansky et al, 1992.
Study Incidence of thyroid disorders
Prentice at al, 1999 36%
Wilansky et al, 1992 22%
Present study 24%
Menon et al, 1995 26%
Some  patients  have  a  normal  serum  TSH  despite  low  T3 and  T4.  This  is 
explained by a downward resetting of the threshold for TSH inhibition TSH 
setpoint for a particular serum T3, T4 increases with age and is also altered by 
personal  and  familial  character.  TSH  values  tend  to  change  more  rapidly 
because the half life of TSH is much shorter than T3 and T4. This should be 
considered  with  regard  to  abnormal  relationships  between  T3,  T4 and  TSH. 
There  are  some  variations  which  should  be  given  due  consideration  before 
interpreting the results.
1) T4- Methodology, pregnancy
2) TSH – diurnal variation, pulsatile secretion
Alteration in the relationship between T4and TSH can be caused by alternate 
thyroid stimulating hormones like TSH isoforms, chorionic gonadotrophins, and 
TSH receptor stimulating antibody. It can be caused by hormones and drugs like 
glucocorticoids,  severe  non-thyroidal  illness,  recent  thyrotoxicosis  and  long 
standing  hypothyroidism.  The  incidence  of  thyroid  dysfunction  in  the 
population  with  AUB  is  24%  according  to  our  study  and  hence  selective 
screening of this population would result in a higher yield.
A major benefit of routine testing is the earlier detection of unsuspected overt 
thyrotoxicosis  or  subclinical  hypothyroidism  or  hyperthyroidism.  Most 
clinicians  advocate treatment of women with elevated TSH levels in view of 
risk of hypothyroidism subsequently. 
T3  - Binding protein ,its values are altered in the following conditions 
like illness ,surgery,  drugs and age related changes,
A T3  T4 TSH  assay can be used as a management tool besides its use in 
diagnosis  and screening A T3 :  T4 eatio  of  greater  than 0.024 during drug 
therapy  suggests that  remission is unlikely . it can be used to identify patients 
who have persistent T3 excess despite normal a low serum T4 levels during anti 
thyroid therapy. It  can be used to distinguish between T3 thyrotoxicosis and 
subclinical thyrotoxicosis in patients with low TSH.
SUMMARY
The present study is a cross-sectional study of 250 women with abnormal 
uterine bleeding in the reproductive age group undertaken in a tertiary referral 
hospital over a period of 10 months.  It was done to ascertain the correlation 
between  thyroid dysfunction and AUB.
The  history  was  elicited  according to  the  proforma.   Anthroprometric 
measurement  were taken and a detailed examination was done.  T3, T4 and TSH 
levels were evaluated in the fasting rate and the results interpreted.
1. The  study  showed  a  significant  correlation  (p  =  0.004,  significant) 
between increasing age and thyroid dysfunction.
2. The  general   examination   showed a  significant  correlation  (p=0.003) 
with thyroid dysfunction.
3. The Body Mass Index showed a significant correlation (p=0.006) with 
thyroid dysfunction.
4. The  study  showed  a  significant  correlation  (p=0.006)  between 
Hemoglobin Estimation and thyroid dysfunction.
5. The  Study  showed  a  significant  correlation  between  thyroid   profile 
( T3,T4 and TSH ) and AUB (p=0.003).
6. The  study  showed  a  significant  correlation   (p=0.002,  Significant  ) 
between  fractional  curettage  and  hypothyroidism  whereas  in 
hyperthyroidism as the endometrial pattern is unpredictable, it was not 
significant. 
                                            CONCLUSION
It  may be concluded from the present  study that  there is  a significant 
association between thyroid disorders and AUB. The high incidence (24%)of 
thyroid disorders in women with AUB, particularly if the 5-10% of subclinical 
hypothyroidism is included, justifies the cost of screening in  AUB population. 
The risk of progression to overt hypothyroidism (about 5% per year) in patients 
with  subclinical  disease  also  emphasize  the  need  for  screening  in  AUB 
population.
PROFORMA
Name Age 
Address Parity 
Sterilisation 
H/O O/E
Menorrhagia General Condition 
Oligomennorrhe Anemia 
Amenorrhea Thyromegaly 
Polymenorrhea BMI
Others 
H/O S/S Hyperthyroidism Thyroid function tests 
                                                                     T3
--------------------- T4
-------------------------------- TSH
--------------------- Inference 
H/O S/S Hypothyroidism other Investigation 
------------------- Hb in gm/dl
------------------ Fractional  Curettage 
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ABBREVIATIONS
AUB - Abnormal Uterine Bleeding
T4 - Thyroxine
T3 - Tri-iodothyronine
TSH - Thyroid Stimulating Hormone
TRH - Thyrotropin Releasing Hormone
LH - Luteinising Hormone
FSH - Follicular Stimulating Hormone
HCG - Human Chorionic Hormone
TR - Thyroid hormone Receptor
RXR - Retinoid X Receptor
RT3 - Reverse T3
TBG - Thyroid Binding Globulin
SHBG - Sex Hormone Binding Globulin
FT4 - Free Thyroxine
TT4 - Total Thyroxine
GnRH - Gonadotrophin Releasing Hormone
Anti TPO - Anti Thyroid Peroxidase
Anti TG - Anti Thyroglobulin
BMI - Body Mass Index
PID - Pelvic Inflammatory Disease
IUCD - Intra Uterine Contraceptive Device
IRMA - Immuno Radio Metric Assay
BRIT - Board of Radiation and Isotope Technology
ACOG - American College of Obstetric and Gynaecology
